SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-134769
Filing Date
2016-11-15
Accepted
2016-11-15 17:11:47
Documents
12
Period of Report
2016-11-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v453193_8k.htm 8-K 37778
2 EXHIBIT 1.1 v453193_ex1-1.htm EX-1.1 202788
3 EXHIBIT 4.1 v453193_ex4-1.htm EX-4.1 22773
4 EXHIBIT 4.2 v453193_ex4-2.htm EX-4.2 42010
5 EXHIBIT 4.3 v453193_ex4-3.htm EX-4.3 178269
6 EXHIBIT 5.1A v453193_ex5-1a.htm EX-5.1A 11935
7 EXHIBIT 5.1B v453193_ex5-1b.htm EX-5.1B 10241
8 EXHIBIT 99.1 v453193_ex99-1.htm EX-99.1 11520
9 EXHIBIT 99.2 v453193_ex99-2.htm EX-99.2 11800
10 GRAPHIC logo_ex5-1b.jpg GRAPHIC 19971
11 GRAPHIC logo_ex99-1.jpg GRAPHIC 21021
12 GRAPHIC logo_ex99-2.jpg GRAPHIC 21021
  Complete submission text file 0001144204-16-134769.txt   616409
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 162000511
SIC: 2834 Pharmaceutical Preparations